InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Bryan Nancy. Director active across 1 company, notably AIM ImmunoTech Inc.. In total, 9 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. History available since 21 March 2024. The latest transaction was filed on 14 March 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
BRYAN NANCY is a declarant and a director at AIM ImmunoTech Inc. (XNAS). The data block shows 9 filings in total, and across the 9 sampled filings the transactions run from 2024-03-22 to 2025-03-18, with EUR 13715 of buys and EUR 0 of sells; the most common transaction nature is Attribution.